{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:48:36Z","timestamp":1788324516623,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02246-w","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:43:44Z","timestamp":1766058224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular surveillance of antimalarial drug resistance genes in Nigeria: a systematic review and roadmap to malaria elimination"],"prefix":"10.1186","volume":"18","author":[{"given":"Oluwayemi J.","family":"Bamikole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayorinde F.","family":"Fayehun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaaqub A.","family":"Uthman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem A.","family":"Salako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babajide A.","family":"Adedeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles-Dei B.","family":"Olufeagba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olukemi K.","family":"Amodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2246_CR1","unstructured":"WHO. World Malaria Report. vol. WHO\/HTM\/GM. 2023. https:\/\/doi.org\/ISBN 978 92 4 1564403."},{"key":"2246_CR2","unstructured":"FMoH. Malaria Indicator Survey (MIS) 2015 2015."},{"key":"2246_CR3","doi-asserted-by":"publisher","first-page":"701750","DOI":"10.3389\/fgene.2021.701750","volume":"12","author":"H Zhao","year":"2021","unstructured":"Zhao H, Pi L, Zhao L, Qin Y, Zeng W, Xiang Z, et al. First detection in West Africa of a mutation that May contribute to Artemisinin resistance plasmodium falciparum. Front Genet. 2021;12:701750. https:\/\/doi.org\/10.3389\/fgene.2021.701750.","journal-title":"Front Genet"},{"key":"2246_CR4","doi-asserted-by":"publisher","first-page":"201104","DOI":"10.1016\/j.humgen.2022.201104","volume":"34","author":"OJ Bamikole","year":"2022","unstructured":"Bamikole OJ, Ademola SA, Agatha-christie D, Yellow SI, Etim J, Ajige A, et al. Genetic variability (785A\u2009>\u2009G, 516G\u2009>\u2009T and 64C\u2009>\u2009T) in the CYP2B6 gene among individuals in Southwest Nigeria : implications for malaria treatment. Hum Gene. 2022;34:201104. https:\/\/doi.org\/10.1016\/j.humgen.2022.201104.","journal-title":"Hum Gene"},{"key":"2246_CR5","unstructured":"World Health Organization. World malaria report 2022. 2022."},{"key":"2246_CR6","doi-asserted-by":"publisher","unstructured":"Ademola SA, Bamikole OJ, Amodu OK. Is TNF alpha a mediator in the co-existence of malaria and type 2 diabetes in a malaria endemic population ? 2023:1\u20138. https:\/\/doi.org\/10.3389\/fimmu.2023.1028303","DOI":"10.3389\/fimmu.2023.1028303"},{"key":"2246_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","volume":"18","author":"R Amato","year":"2018","unstructured":"Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in Southeast asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337\u201345. https:\/\/doi.org\/10.1016\/S1473-3099(18)30068-9.","journal-title":"Lancet Infect Dis"},{"key":"2246_CR8","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1128\/AAC.47.8.2418-2423.2003","volume":"47","author":"AL Pickard","year":"2003","unstructured":"Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, et al. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in Pfmdr1. Antimicrob Agents Chemother. 2003;47:2418\u201323. https:\/\/doi.org\/10.1128\/AAC.47.8.2418-2423.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"2246_CR9","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad MD, Rosenthal PJ. Antimalarial drug resistance in africa: the calm before the storm? Lancet Infect Dis. 2019;19:e338\u201351. https:\/\/doi.org\/10.1016\/S1473-3099(19)30261-0.","journal-title":"Lancet Infect Dis"},{"key":"2246_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-2947-z","volume":"18","author":"AO Idowu","year":"2019","unstructured":"Idowu AO, Oyibo WA, Bhattacharyya S, Khubbar M, Mendie UE, Bumah VV, et al. Rare mutations in Pfmdr1 gene of plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria. Malar J. 2019;18:1\u20139. https:\/\/doi.org\/10.1186\/s12936-019-2947-z.","journal-title":"Malar J"},{"key":"2246_CR11","doi-asserted-by":"publisher","unstructured":"Bamikole OJ, Olajide TH, Adedeji BA, Ademola SA, Fayehun AF, Bukoye NO et al. Drug use practices and Self-treatment for suspected malaria in Ibadan, Nigeria. Am J Trop Med 2023:1\u20135. https:\/\/doi.org\/10.4269\/ajtmh.22-0489","DOI":"10.4269\/ajtmh.22-0489"},{"key":"2246_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50152-w","volume":"9","author":"SJ Patgiri","year":"2019","unstructured":"Patgiri SJ, Sarma K, Sarmah N, Bhattacharyya N, Sarma DK, Nirmolia T, et al. Characterization of drug resistance and genetic diversity of plasmodium falciparum parasites from Tripura, Northeast India. Sci Rep. 2019;9:1\u201310. https:\/\/doi.org\/10.1038\/s41598-019-50152-w.","journal-title":"Sci Rep"},{"key":"2246_CR13","doi-asserted-by":"publisher","unstructured":"White NJ. Review series Antimalarial drug resistance 2004;113. https:\/\/doi.org\/10.1172\/JCI200421682.1084","DOI":"10.1172\/JCI200421682.1084"},{"key":"2246_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03942-5","volume":"20","author":"C Nsanzabana","year":"2021","unstructured":"Nsanzabana C. Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa. Malar J. 2021;20:1\u20135. https:\/\/doi.org\/10.1186\/s12936-021-03942-5.","journal-title":"Malar J"},{"key":"2246_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/683167","volume":"2011","author":"M Nanyunja","year":"2011","unstructured":"Nanyunja M, Nabyonga Orem J, Kato F, Kaggwa M, Katureebe C, Saweka J. Malaria treatment policy change and implementation: the case of Uganda. Malar Res Treat. 2011;2011:1\u201314. https:\/\/doi.org\/10.4061\/2011\/683167.","journal-title":"Malar Res Treat"},{"key":"2246_CR16","unstructured":"Ezedinac ENU, Ejezie GC, Emeribe A. Problems of chloroquine-resistant p. Jalciparum Nigeria: One Antimalaria Drugs\u2019 Utilisation Metropolitan Calabar 1991;37."},{"key":"2246_CR17","first-page":"441","volume":"2","author":"PO Erah","year":"2003","unstructured":"Erah PO, Arienmughare G, Okhamafe AO. Plasmodium falciparum malaria resistance to chloroquine in five communities in Southern Nigeria. Afr J Biotechnol. 2003;2:441\u201352.","journal-title":"Afr J Biotechnol"},{"key":"2246_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1365-3156.2005.01503.x","volume":"10","author":"A Sowunmi","year":"2005","unstructured":"Sowunmi A, Fehintola FA, Adedeji AA, Gbotosho GO, Tambo E, Fateye BA, et al. Open randomized study of artesunate-amodiaquine vs. chloroquine- pyrimethamine-sulfadoxine for the treatment of uncomplicated plasmodium falciparum malaria in Nigerian children. Trop Med Int Heal. 2005;10:1161\u201370. https:\/\/doi.org\/10.1111\/j.1365-3156.2005.01503.x.","journal-title":"Trop Med Int Heal"},{"key":"2246_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-7-24","volume":"7","author":"IO Ajayi","year":"2008","unstructured":"Ajayi IO, Falade CO, Bamgboye EA, Oduola AMJ, Kale OO. Assessment of a treatment guideline to improve home management of malaria in children in rural south-west Nigeria. Malar J. 2008;7:1\u201312. https:\/\/doi.org\/10.1186\/1475-2875-7-24.","journal-title":"Malar J"},{"key":"2246_CR20","doi-asserted-by":"publisher","unstructured":"Ajogbasile FV, Oluniyi PE, Kayode AT, Akano KO, Adegboyega BB, Philip C, et al. Molecular profiling of the Artemisinin resistance Kelch 13 gene in plasmodium falciparum from Nigeria. PLoS ONE. 2022;17. https:\/\/doi.org\/10.1371\/journal.pone.0264548.","DOI":"10.1371\/journal.pone.0264548"},{"key":"2246_CR21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1111\/febs.14127","volume":"284","author":"AM Thu","year":"2017","unstructured":"Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrug-resistant plasmodium falciparum malaria. FEBS J. 2017;284:2569\u201378. https:\/\/doi.org\/10.1111\/febs.14127.","journal-title":"FEBS J"},{"key":"2246_CR22","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","volume":"20","author":"M Imwong","year":"2020","unstructured":"Imwong M, Dhorda M, Myo Tun K, Thu AM, Phyo AP, Proux S, et al. Molecular epidemiology of resistance to antimalarial drugs in the greater Mekong subregion: an observational study. Lancet Infect Dis. 2020;20:1470\u201380. https:\/\/doi.org\/10.1016\/S1473-3099(20)30228-0.","journal-title":"Lancet Infect Dis"},{"key":"2246_CR23","doi-asserted-by":"publisher","unstructured":"Folarin OA, Gbotosho GO, Sowunmi A, Olorunsogo OO, Oduola AMJ, Happi TC. Chloroquine resistant plasmodium falciparum in nigeria: relationship between Pfcrt and Pfmdr1 polymorphisms. In-Vitro Resist Treat Outcome 2009:74\u201382. Chloroquine https:\/\/doi.org\/10.2174\/1874315300801010074","DOI":"10.2174\/1874315300801010074"},{"key":"2246_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-020-05334-5","volume":"13","author":"M Tola","year":"2020","unstructured":"Tola M, Ajibola O, Idowu ET, Omidiji O, Awolola ST, Amambua-Ngwa A. Molecular detection of drug resistant polymorphisms in plasmodium falciparum isolates from Southwest, Nigeria. BMC Res Notes. 2020;13:1\u20137. https:\/\/doi.org\/10.1186\/s13104-020-05334-5.","journal-title":"BMC Res Notes"},{"key":"2246_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-020-00712-4","volume":"9","author":"H Quan","year":"2020","unstructured":"Quan H, Igbasi U, Oyibo W, Omilabu S, Chen SB, Shen HM, et al. High multiple mutations of plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria. Infect Dis Poverty. 2020;9:1\u201311. https:\/\/doi.org\/10.1186\/s40249-020-00712-4.","journal-title":"Infect Dis Poverty"},{"key":"2246_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijpara.2020.10.001","volume":"51","author":"AT Kayode","year":"2021","unstructured":"Kayode AT, Akano K, Ajogbasile FV, Uwanibe JN, Oluniyi PE, Bankole BE, et al. Polymorphisms in plasmodium falciparum chloroquine resistance transporter (Pfcrt) and multidrug-resistant gene 1 (Pfmdr-1) in Nigerian children 10 years post-adoption of artemisinin-based combination treatments. Int J Parasitol. 2021;51:301\u201310. https:\/\/doi.org\/10.1016\/j.ijpara.2020.10.001.","journal-title":"Int J Parasitol"},{"key":"2246_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4314\/njpar.v44i1.19","volume":"44","author":"KA Obaniyi","year":"2023","unstructured":"Obaniyi KA, Sunday OJ, Oso GO, Olalubi O. Mutant DHFR prevalence and pyrimethamine resistance among asymptomatic adolescents in Kwara state. Niger J Parasitol. 2023;44:191\u2013200. https:\/\/doi.org\/10.4314\/njpar.v44i1.19.","journal-title":"Niger J Parasitol"},{"key":"2246_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12639-022-01538-7","volume":"47","author":"OJ Afolabi","year":"2023","unstructured":"Afolabi OJ, Oluwafemi OR, Oniya MO. P Fmdr 1 and Kelch 13 genes distribution among children that are 5 years and below in Akure, Nigeria. J Parasit Dis. 2023;47:59\u201367. https:\/\/doi.org\/10.1007\/s12639-022-01538-7.","journal-title":"J Parasit Dis"},{"key":"2246_CR29","doi-asserted-by":"publisher","unstructured":"Balogun ST, Sandabe UK, Sodipo OA, Okon KO, Akanmu AO. Single nucleotide polymorphisms of Pfdhfr and Pfdhps genes: implications for malaria prophylactic strategies in Maiduguri, Northeast Nigeria. J Trop Med. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/8840089.","DOI":"10.1155\/2021\/8840089"},{"key":"2246_CR30","doi-asserted-by":"publisher","first-page":"105042","DOI":"10.1016\/j.meegid.2021.105042","volume":"95","author":"CO Agomo","year":"2021","unstructured":"Agomo CO, Mishra N, Olukosi YA, Gupta R, Kamlesh K, Aina OO, et al. Mutations in Pfcrt and Pfmdr1 genes of plasmodium falciparum isolates from two sites in northcentral and Southwest Nigeria. Infect Genet Evol. 2021;95:105042. https:\/\/doi.org\/10.1016\/j.meegid.2021.105042.","journal-title":"Infect Genet Evol"},{"key":"2246_CR31","doi-asserted-by":"publisher","unstructured":"Ikegbunam M, Ojo JA, Kokou K, Morikwe U, Nworu C, Uba C et al. Absence of plasmodium falciparum Artemisinin resistance gene mutations eleven years after the adoption of Artemisinin \u2013 based combination therapy in Nigeria. Malar J 2021:1\u20136. https:\/\/doi.org\/10.1186\/s12936-021-03968-9","DOI":"10.1186\/s12936-021-03968-9"},{"key":"2246_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/diseases9010006","volume":"9","author":"R Adam","year":"2021","unstructured":"Adam R, Mukhtar MM, Abubakar UF, Damudi HA, Muhammad A, Ibrahim SS. Polymorphism analysis of Pfmdr1 and Pfcrt from plasmodium falciparum isolates in Northwestern Nigeria revealed the major markers associated with antimalarial resistance. Diseases. 2021;9:6. https:\/\/doi.org\/10.3390\/diseases9010006.","journal-title":"Diseases"},{"key":"2246_CR33","doi-asserted-by":"crossref","unstructured":"Abubakar UF, Adam R, Mukhtar MM, Muhammad A, Yahuza AA, Ibrahim SS. Identification of mutations in antimalarial resistance gene Kelch13 from plasmodium falciparum isolates in Kano, Nigeria. Trop Med Infect Dis Artic; 2020.","DOI":"10.3390\/tropicalmed5020085"},{"key":"2246_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-2833-8","volume":"18","author":"TM Dokunmu","year":"2019","unstructured":"Dokunmu TM, Adjekukor CU, Yakubu OF, Bello AO, Adekoya JO, Akinola O, et al. Asymptomatic malaria infections and Pfmdr1 mutations in an endemic area of Nigeria. Malar J. 2019;18:1\u20137. https:\/\/doi.org\/10.1186\/s12936-019-2833-8.","journal-title":"Malar J"},{"key":"2246_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/tmi.13273","volume":"24","author":"U Igbasi","year":"2019","unstructured":"Igbasi U, Oyibo W, Omilabu S, Quan H, Chen SB, Shen HM, et al. Kelch 13 propeller gene polymorphism among plasmodium falciparum isolates in Lagos, nigeria: molecular epidemiologic study. Trop Med Int Heal. 2019;24:1011\u20137. https:\/\/doi.org\/10.1111\/tmi.13273.","journal-title":"Trop Med Int Heal"},{"key":"2246_CR36","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2147\/IDR.S190386","volume":"12","author":"GI Olasehinde","year":"2019","unstructured":"Olasehinde GI, Diji-Geske RI, Fadina I, Arogundade D, Darby P, Adeleke A, et al. Epidemiology of plasmodium falciparum infection and drug resistance markers in Ota area, Southwestern Nigeria. Infect Drug Resist. 2019;12:1941\u20139. https:\/\/doi.org\/10.2147\/IDR.S190386.","journal-title":"Infect Drug Resist"},{"key":"2246_CR37","doi-asserted-by":"crossref","unstructured":"Oboh MA, Ndiaye D, Antony HA, Badiane AS, Singh US, Ali NA et al. Status of Artemisinin resistance in malaria parasite plasmodium falciparum from molecular analyses of the Kelch13 gene in Southwestern Nigeria 2018;2018.","DOI":"10.1155\/2018\/2305062"},{"key":"2246_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.meegid.2018.10.007","volume":"66","author":"MA Oboh","year":"2018","unstructured":"Oboh MA, Singh US, Antony HA, Ndiaye D, Badiane AS, Ali NA, et al. Molecular epidemiology and evolution of drug-resistant genes in the malaria parasite plasmodium falciparum in Southwestern Nigeria. Infect Genet Evol. 2018;66:222\u20138. https:\/\/doi.org\/10.1016\/j.meegid.2018.10.007.","journal-title":"Infect Genet Evol"},{"key":"2246_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bjbas.2017.07.009","volume":"7","author":"IA Simon-Oke","year":"2018","unstructured":"Simon-Oke IA, Obimakinde ET, Afolabi OJ. Prevalence and distribution of malaria, Pfcrt and Pfmdr 1 genes in patients attending FUT health Centre, Akure, Nigeria. Beni-Suef Univ J Basic Appl Sci. 2018;7:98\u2013103. https:\/\/doi.org\/10.1016\/j.bjbas.2017.07.009.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"2246_CR40","first-page":"15","volume":"8","author":"RH Muhammad","year":"2017","unstructured":"Muhammad RH, Nock IH, Ndams IS, George JB, Deeni Y. Distribution of Pfmdr1 and Pfcrt chloroquine drug resistance alleles in north-western Nigeria. MalariaWorld J. 2017;8:15.","journal-title":"MalariaWorld J"},{"key":"2246_CR41","first-page":"13","volume":"8","author":"OT Soniran","year":"2017","unstructured":"Soniran OT, Idowu OA, Ogundapo SS. Factors associated with high prevalence of Pfcrt K76T mutation in plasmodium falciparum isolates in a rural and urban community of Ogun State, Nigeria. MalariaWorld J. 2017;8:13.","journal-title":"MalariaWorld J"},{"key":"2246_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3855\/jidc.6853","volume":"10","author":"ST Balogun","year":"2016","unstructured":"Balogun ST, Sandabe UK, Bdliya DN, Adedeji WA, Okon KO, Fehintola FA. Asymptomatic falciparum malaria and genetic polymorphisms of Pfcrt K76T and Pfmdr1 N86Y among Almajirai in Northeast Nigeria. J Infect Dev Ctries. 2016;10:290\u20137. https:\/\/doi.org\/10.3855\/jidc.6853.","journal-title":"J Infect Dev Ctries"},{"key":"2246_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7324\/JAPS.2016.60403","volume":"6","author":"AE Emilia","year":"2016","unstructured":"Emilia AE, Victoria UC, Christian MA, Okechukwu NE. Prevalence of Pfmdr 1 N86Y and Y184F alleles is associated with recurrent parasitemia following treatment of uncomplicated malaria with artemether-lumefantrine in Nigerian patients. J Appl Pharm Sci. 2016;6:15\u201321. https:\/\/doi.org\/10.7324\/JAPS.2016.60403.","journal-title":"J Appl Pharm Sci"},{"key":"2246_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13000-015-0276-2","volume":"10","author":"OO Oladipo","year":"2015","unstructured":"Oladipo OO, Wellington OA, Sutherland CJ. Persistence of chloroquine-resistant haplotypes of plasmodium falciparum in children with uncomplicated malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine. Diagn Pathol. 2015;10:4\u201311. https:\/\/doi.org\/10.1186\/s13000-015-0276-2.","journal-title":"Diagn Pathol"},{"key":"2246_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.actatropica.2011.08.013","volume":"120","author":"OA Folarin","year":"2011","unstructured":"Folarin OA, Bustamante C, Gbotosho GO, Sowunmi A, Zalis MG, Oduola AMJ, et al. In vitro amodiaquine resistance and its association with mutations in Pfcrt and Pfmdr1 genes of plasmodium falciparum isolates from Nigeria. Acta Trop. 2011;120:224\u201330. https:\/\/doi.org\/10.1016\/j.actatropica.2011.08.013.","journal-title":"Acta Trop"},{"key":"2246_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00508-010-1484-0","volume":"122","author":"O Ojurongbe","year":"2010","unstructured":"Ojurongbe O, Oyedeji SI, Oyibo WA, Fagbenro-Beyioku AF, Kun JF. Molecular surveillance of drug-resistant plasmodium falciparum in two distinct geographical areas of Nigeria. Wien Klin Wochenschr. 2010;122:681\u20135. https:\/\/doi.org\/10.1007\/s00508-010-1484-0.","journal-title":"Wien Klin Wochenschr"},{"key":"2246_CR47","first-page":"389","volume":"99","author":"WB Plummer","year":"2004","unstructured":"Plummer WB, Pereira LMP, Carrington CVF. Pfcrt and Pfmdr1 alleles associated with chloroquine resistance in plasmodium falciparum from Guyana. South Am. 2004;99:389\u201392.","journal-title":"South Am"},{"key":"2246_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1590\/S0074-02762012000100018","volume":"107","author":"G Awasthi","year":"2012","unstructured":"Awasthi G, Satya GBK, Das A. Pfcrt haplotypes and the evolutionary history of chloroquine-resistant plasmodium falciparum. Mem Inst Oswaldo Cruz. 2012;107:129\u201334. https:\/\/doi.org\/10.1590\/S0074-02762012000100018.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2246_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03281-x","volume":"19","author":"FT Foguim","year":"2020","unstructured":"Foguim FT, Bogreau H, Gendrot M, Mosnier J, Fonta I, Benoit N, et al. Prevalence of mutations in the plasmodium falciparum chloroquine resistance transporter, Pfcrt, and association with ex vivo susceptibility to common anti-malarial drugs against African plasmodium falciparum isolates. Malar J. 2020;19:1\u20139. https:\/\/doi.org\/10.1186\/s12936-020-03281-x.","journal-title":"Malar J"},{"key":"2246_CR50","first-page":"183","volume":"1","author":"AG Schneider","year":"2002","unstructured":"Schneider AG, Premji Z. A point mutation in codon 76 of Pfcrt of P. falciparum is positively selected for by chloroquine. Treat Tanzan. 2002;1:183\u20139.","journal-title":"Treat Tanzan"},{"key":"2246_CR51","doi-asserted-by":"publisher","unstructured":"Happi TC, Thomas SM, Gbotosho GO, Falade CO, Akinboye DO, Gerena L et al. Point mutations in the Pfcrt and Pfmdr-1 genes of plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria 2003;97:439\u201351. https:\/\/doi.org\/10.1179\/000349803235002489","DOI":"10.1179\/000349803235002489"},{"key":"2246_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12936-020-03543-8","volume":"20","author":"PTN Niba","year":"2021","unstructured":"Niba PTN, Nji AM, Evehe M-S, Ali IM, Netongo PM, Ngwafor R, et al. Drug resistance markers within an evolving efficacy of anti-malarial drugs in cameroon: a systematic review and meta-analysis (1998\u20132020). Malar J. 2021;20:32. https:\/\/doi.org\/10.1186\/s12936-020-03543-8.","journal-title":"Malar J"},{"key":"2246_CR53","unstructured":"Zhao Y, Liu Z, Soe MT, Wang L, Soe TN, Wei H et al. Genetic variations associated with drug resistance markers in asymptomatic plasmodium. Falciparum N D:1\u201317."},{"key":"2246_CR54","doi-asserted-by":"publisher","unstructured":"Mvumbi DM, Kayembe JM, Situakibanza H, Bobanga TL, Nsibu CN, Mvumbi GL et al. Falciparum malaria molecular drug resistance in the Democratic Republic of congo: a systematic review. Malar J 2015:1\u20136. https:\/\/doi.org\/10.1186\/s12936-015-0892-z","DOI":"10.1186\/s12936-015-0892-z"},{"key":"2246_CR55","first-page":"114","volume":"51","author":"B Uzochukwu","year":"2010","unstructured":"Uzochukwu B, Ezeoke OP, Emma-Ukaegbu U, Onwujekwe OESF. Malaria treatment services in nigeria: A review. Niger Med J. 2010;51:114.","journal-title":"Niger Med J"},{"key":"2246_CR56","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1086\/649784","volume":"201","author":"C Nsanzabana","year":"2010","unstructured":"Nsanzabana C, Hastings IM, Marfurt J, M\u00fcller I, Baea K, Rare L, et al. Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua new Guinea. J Infect Dis. 2010;201:435\u201343. https:\/\/doi.org\/10.1086\/649784.","journal-title":"J Infect Dis"},{"key":"2246_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-5-76","volume":"5","author":"JM Chuma","year":"2006","unstructured":"Chuma JM, Thiede M, Molyneux CS. Rethinking the economic costs of malaria at the household level: evidence from applying a new analytical framework in rural Kenya. Malar J. 2006;5:1\u201314. https:\/\/doi.org\/10.1186\/1475-2875-5-76.","journal-title":"Malar J"},{"key":"2246_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-1849-1","volume":"16","author":"PE Anyanwu","year":"2017","unstructured":"Anyanwu PE, Fulton J, Evans E, Paget T. Exploring the role of socioeconomic factors in the development and spread of anti-malarial drug resistance: a qualitative study. Malar J. 2017;16:1\u201315. https:\/\/doi.org\/10.1186\/s12936-017-1849-1.","journal-title":"Malar J"},{"key":"2246_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-10-99","volume":"10","author":"CA Watsierah","year":"2011","unstructured":"Watsierah CA, Jura WG, Raballah E, Kaseje D, Abong\u2019O B, Ouma C. Knowledge and behaviour as determinants of anti-malarial drug use in a peri-urban population from malaria holoendemic region of Western Kenya. Malar J. 2011;10:1\u20137. https:\/\/doi.org\/10.1186\/1475-2875-10-99.","journal-title":"Malar J"},{"key":"2246_CR60","doi-asserted-by":"publisher","unstructured":"Anyanwu PE, Fulton J. Socioeconomic determinants of antimalarial drug use behaviours: A systematic review. J Community Public Heal Nurs. 2016;2. https:\/\/doi.org\/10.4172\/2471-9846.1000123.","DOI":"10.4172\/2471-9846.1000123"},{"key":"2246_CR61","unstructured":"KPMG. The global economic impact of anti-microbial resistance 2014."},{"key":"2246_CR62","doi-asserted-by":"publisher","unstructured":"Zhao D, Zhang H, Ji P, Li S, Yang C, Liu Y et al. Surveillance of antimalarial Drug-Resistance genes in imported plasmodium falciparum isolates from Nigeria in Henan, 2021;11:1\u20139. https:\/\/doi.org\/10.3389\/fcimb.2021.644576","DOI":"10.3389\/fcimb.2021.644576"},{"key":"2246_CR63","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1016\/S2666-5247(20)30094-X","volume":"1","author":"HY Ehrlich","year":"2020","unstructured":"Ehrlich HY, Jones J, Parikh S. Molecular surveillance of antimalarial partner drug resistance in sub-Saharan africa: a spatial-temporal evidence mapping study. Lancet Microbe. 2020;1:e209\u201317. https:\/\/doi.org\/10.1016\/S2666-5247(20)30094-X.","journal-title":"Lancet Microbe"},{"key":"2246_CR64","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4236\/ojpm.2012.23056","volume":"02","author":"NE Harrison","year":"2012","unstructured":"Harrison NE, Olufunlayo TF, Agomo CO. Utilization of the current National antimalarial treatment guidelines among Doctors in army hospitals in Lagos, Nigeria. Open J Prev Med. 2012;02:390\u20133. https:\/\/doi.org\/10.4236\/ojpm.2012.23056.","journal-title":"Open J Prev Med"},{"key":"2246_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04115-8","author":"CV Plowe","year":"2022","unstructured":"Plowe CV. Malaria chemoprevention and drug resistance: a review of the literature and policy implications. Malar J. 2022. https:\/\/doi.org\/10.1186\/s12936-022-04115-8.","journal-title":"Malar J"},{"key":"2246_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-023-04825-7","volume":"23","author":"T Ibinaiye","year":"2024","unstructured":"Ibinaiye T, Rotimi K, Balogun A, Aidenagbon A, Oguoma C, Baker K, et al. Urban\u2013rural differences in seasonal malaria chemoprevention coverage and characteristics of target populations in nine States of nigeria: a comparative cross-sectional study. Malar J. 2024;23:1\u20139. https:\/\/doi.org\/10.1186\/s12936-023-04825-7.","journal-title":"Malar J"},{"key":"2246_CR67","doi-asserted-by":"publisher","first-page":"1366563","DOI":"10.3389\/fcimb.2024.1366563","volume":"14","author":"O Ajibaye","year":"2024","unstructured":"Ajibaye O, Olukosi YA, Oriero EC, Oboh MA, Iwalokun B, Nwankwo IC, et al. Detection of novel plasmodium falciparum Coronin gene mutations in a recrudescent ACT-treated patient in South-Western Nigeria. Front Cell Infect Microbiol. 2024;14:1366563. https:\/\/doi.org\/10.3389\/fcimb.2024.1366563.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02246-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02246-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02246-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:43:50Z","timestamp":1766058230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-025-02246-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02246-w","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.\u00a0However, all included studies obtained ethical approval from their respective institutional review boards and consent to participate.The protocol of this systematic review was registered with PROSPERO (ID: CRD42023424147). This study is a systematic review based solely on previously published research. No new data involving human participants were collected, and therefore, ethics approval and consent to participate were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0<!--Emphasis Type='Bold' removed-->\u00a0and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}